News
To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...
The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...
4d
Zacks Investment Research on MSNOPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock?OptimizeRx OPRX, a digital health platform that connects pharmaceutical companies with healthcare providers and patients, ...
Life sciences and the pharmaceutical industry are awash with data. ... Good things flow. Silicon Valley-based Treasure Data has developed a range of tools that liberate previously siloed data to ...
It makes sense. Google Analytics 4 (GA4) has shaken things up, cookie consent is a regulatory minefield, and capturing first-party data isn’t just a nice-to-have anymore – it’s survival.
Delivers consolidated governance and real-world data exchange to unlock insights from registries and clinical trials to commercial and beyond </ Tuesday, 02 January 2024 12:17 GMT عربي ...
Harshit suggests that an open ecosystem approach, with seamless data flow between touchpoints, can help brands stitch together a cohesive and personalized customer experience. Listen or read the ...
Martin Shkreli, the former hedge fund manager known as "Pharma Bro," defended Palantir Technologies Inc.'s valuation on Tuesday amid the company's surging stock price, projecting substantial cash ...
U.S. pharmaceutical giant Cencora has been affected by a data breach. The company is notifying affected individuals that their personal and highly sensitive medical information was stolen during a ...
It leverages existing data, like historical EHR, claims and pharma data, to predict a population or patient’s behavioral health needs. NeuroFlow's new tools suite for population risk management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results